Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
202,682
-
Shares change
-
-11,182
-
Total reported value, excl. options
-
$81,276
-
Value change
-
-$38,447
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$0.401
Significant Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) as of Q1 2025
19 filings reported holding HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW as of Q1 2025.
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 202,682 shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (72,000 shares), Grant Private Wealth Management Inc (46,193 shares), GEODE CAPITAL MANAGEMENT, LLC (35,000 shares), CITADEL ADVISORS LLC (27,208 shares), VANGUARD GROUP INC (12,598 shares), IFP Advisors, Inc (5,000 shares), Tower Research Capital LLC (TRC) (3,902 shares), SBI Securities Co., Ltd. (454 shares), CoreCap Advisors, LLC (200 shares), and American Capital Advisory, LLC (61 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.